Experimental Section
General Methods.
All reagents were purchased from Sigma-Aldrich unless otherwise stated. 2-fluoroethyl-4methylbenzene sulfonate was prepared using literature procedure 1 . 1 H NMR, proton-decoupled 13 C NMR, and 19 F NMR spectra were recorded on a Varian 400 MHz spectrometer; chemical shifts are reported in δ (ppm) with reference to either TMS or trichlorofluoromethane (CFCl 3 ). Mass spectra were obtained from the University of Missouri, Mass Spectrometry facility using nitrobenzyl alcohol (NBA) as matrix and analyzed via HRFab. Purity of the 4 was assessed using an HPLC (Waters system 600 equipped with dual λ-detector 2487 set to 280 and 365 nm) with a C-18 reversed-phase column (Vydac, 10μm, 100 Å) using an eluent mixture of acetonitrile and water as a gradient system (50% acetonitrile in water for 5 min; 50-100% acetonitrile in water for 5-25 min, 100% acetonitrile from 25-30 min, and finally 50% acetonitrile in water from 35-50 min, at a flow of 1 mL/min).
Chemical Synthesis.
6-methoxy-2-methyl benzothiazole (1)
N-(2-iodo-4-methoxyphenyl)acetamide was coupled with sodium sulfide, in the presence of copper (I) iodide as a catalyst, to obtain 1 using literature procedure 2 and characterized to confirm its identity and formulation.
(E)-5-(2-(6-methoxybenzo[d]thiazol-2-yl)vinyl)-N,N-dimethylpyridin-2-amine (2)
To a mixture of 6-methoxy-2-methyl benzothiazole (1.0 mmol) and 6-dimethylamino pyridine carbaldehyde (1.0 mmol) in DMSO was added 50 % KOH aqueous solution (10 mL). The resulting mixture was stirred at room temperature for 12 h. After the completion of the reaction, the reaction mixture was filtered and the resulted solid was washed with water (3 × 5mL). The wet solid was re-dissolved in DCM (15 mL), washed with water (3 × 5 mL), and combined organic extract was dried over the sodium sulfate. The contents were filtered and concentrated under reduced pressure to obtain a yellow solid (2; 0.28 g; 92%; Rf = 0.62 , 3:2 hexane: EtOAc) and used for the next step without purification. 14, 55.79, 104.13, 106.05, 115.31, 118.0, 119.41, 123.02, 134.08, 134.22, 148.93, 159.15, 165.33; HRMS (FAB) 
(E)-2-(2-(6-(dimethylamino)pyridin-3-yl)vinyl)benzo[d]thiazol-6-ol (3)
The condensed product 2 (0.1 g, 0.3 mmol) was dissolved in dry DCM (5mL) under argon, cooled to -78 °C, stirred for 5 min, and treated with drop-wise addition of BBr 3 (1M in DCM, 0.15 mL, 5.0 mmol). The resulting mixture was slowly brought to room temperature and stirred overnight.
Following completion of the reaction (monitored by TLC), the reaction mixture was cooled to 0°C and quenched with cold satd. sodium bicarbonate solution (5 mL). The reaction mixture was extracted with ethyl acetate (2 × 25 mL), combined extract was washed with water (2 × 10 mL), dried over anhydrous sodium sulfate, filtered, and the filtrates were evaporated under reduced pressure. The residual red solid was purified by flash chromatography using hexane: EtOAc : MeOH (10: 9: 1) as an eluent mixture to obtain 3 (0.08 g; 86%; Rf = 0.24) 04, 106.51, 107.08, 116.11, 118.03, 119.58, 123.17, 134.13, 134.96, 135.60, 147.47, 149.36, 155.90, 159.25, 163.97 ; HRMS (FAB) m/z calc. for C 16 H 16 N 3 OS:
[M+1] + 298.1014; found: 298.1015.
(E)-5-(2-(6-(2-fluoroethoxy)benzo[d]thiazol-2-yl)vinyl)-N,N-dimethylpyridin-2-amine (4)
To a solution of alcohol derivative 3 (0.15 g, 0.5 mmol) in DMF (2mL) and 2-fluoroethyltosylate 1 (0.1g, 0.4 mmol) dissolved in DMF (3mL) was added Cs 2 CO 3 (0.20 g, 0.6 mmol). The contents were stirred at 130°C for 5h. Following completion of the reaction (monitored by TLC), the reaction mixture was quenched with ice-cold water and extracted with ethyl acetate (3 ×25 mL). The combined organic layer was washed with water (2 × 50 mL), dried over anhydrous sodium sulfate, filtered, and the filtrate evaporated under reduced pressure. The crude residue was purified by PTLC using hexane : EtOAc as an eluent mixture (60 : 40) to obtain 4 (0.096 g; 56% ; bright yellow solid; Rf = 0.42; 3:2, EtOAc-hexane).
1 H NMR (400 MHz, CDCl 3 ):  3.14 (s, 6H), 4.20-4.33 (m, 2H), 4.79 (dd, J = 47.6, 8.0 Hz, 2H), 6.51-6.57 (m, 1H), 6.67-6.82 (m, 1H), 7.08 (dd, J = 9.2, 2.6 Hz, 1H), 7. 23-7.34 (m, 1H), 7.30-7.34 (m, 1H), 7.70-7.97 (m, 2H), 8.31 (dd, J = 8.8, 2 .0 Hz 1H); 13 C NMR (100 MHz, CDCl 3 ):  38. 10, 38.13, 67.63, 67.84, 81.01, 82.70, 105.32, 106.05, 115.67, 117.86, 119.34, 123.12, 134.23, 134.33, 148.98, 156.36, 159.17, 165.74; 19 F NMR (282 MHz, CFCl X-ray Crystallography. Crystals suitable for X-ray crystallography were grown by vapor diffusion method by dissolving 4 (4 mg) in methylene chloride and ethyl acetate (1mL; 95:5) in an inner vial and pentane as anti-solvent (1.5 mL) in the outer vial at room temperature over a couple of days.
A single crystal with approximate dimensions 0.446 x 0.204 x 0.089 mm 3 was mounted on a MiTegen loop in a random orientation. Preliminary examination and data collection were performed using a Bruker Kappa Apex II (Charge Coupled Device (CCD) Detector system) single crystal X-Ray diffractometer, equipped with an Oxford Cryostream LT device. All data were collected using graphite monochromated Mo Kα radiation (= 0.71073 Å) from a fine focus sealed tube X-Ray source. Preliminary unit cell constants were determined with a set of 36 narrow frame scans. Collected data set consisted of a combination of  and  scans with a scan width of 0.5°a nd counting time of 20 seconds/frame at a crystal to detector distance of 4.0 cm. The collected frames were integrated using an orientation matrix determined from the narrow frame scans.
Apex II and SAINT software packages 3 were used for data collection and data integration.
Analysis of the integrated data did not show any decay. Final cell constants were determined by global refinement of xyz centroids of 9700 reflections from the complete data set. Collected data were corrected for systematic errors using SADABS 3 based on the Laue symmetry using equivalent reflections. Structure solution and refinement were carried out using the SHELXTL-PLUS software package 3 . The structure was solved by direct methods and refined successfully in the space group, P1. Full matrix least-squares refinement was carried out by minimizing *w(Fo2-Fc2)2. The non-hydrogen atoms were refined anisotropically to convergence. All hydrogen atoms were treated using appropriate riding model (AFIX m3). The F atom was disordered over two positions and was refined to occupancies of 94:6% and was refined with geometrical restraints and displacement constraints. A fragment search of the Cambridge database 4 indicated 31 structures with the fragment C3 to C12, N1, S1. The bond angles and distances for this fragment compare well with the mean distance angles calculated from the data base, using Mogul (Mogul 1.6, Cambridge Structural Data Center) 5 . Analysis of intermolecular interactions shows a weak - interaction and hydrogen bonding. Weak - interaction is also observed between the systems of the phenyl ring (C3 to C8, plane #1) of the benzothiazole ring and the six membered ring C12-C16, N2 (plane #2) with a centroid to centroid distance of 3.826A [plane #1 and #2 (2-x, 2-y, 1-z)] (Olex2, V1.2). Weak hydrogen bonding between nitrogen (N1) and the CH hydrogen Bioassays.
Preparation of Aβ fibrils
Commercially available amyloid peptide Aβ 1-42 (433 µg) was gently dissolved in PBS (1 mL, pH 7.4, 100 µM) 6 . The solution was incubated for 36-48 h at 37°C with continuous gentle shaking to avoid gel formation at the meniscus. The aggregated peptide suspension was stored at -80°C until needed (the suspension did not show any noticeable change in properties for at least 8 weeks 6 ).
Binding of 4 with Aβ fibrils
In vitro binding assays to preformed fibrils were performed using literature procedures 6,7 .
Prior to binding assays, the Aβ fibril stock solution was thawed, diluted with PBS to the final concentration of Aβ fibrils (1µM), and incubated with increasing concentrations of the fluorescent molecule 4 for 30 min. Following excitation at 410nm, fluorescence spectrum of 4 recorded in PBS containing 5% ethanol showed a broad emission peak 450-540nm with E max at 503nm. Upon incubation with preformed of Aβ 1-42 aggregates, the peak at 503nm shifted slightly (E max 485 nm) and showed remarkable enhancement in fluorescence (Figure 3) , indicating binding to Aβ aggregates, similar to enhancement in fluorescence of thioflavin-T in PBS (a positive control; data not shown). Additionally, it is also noteworthy that no fluorescence was observed using Aβ aggregates alone in PBS upon excitation at 410 nm (a negative control). All measurements were made in triplicates; fluorescence of either 4 alone or fibrils at a given concentration was subtracted.
The data were fit to a single site model using GraphPad Prism, version 4.03 (GraphPad Software, San Diego, California, USA) to obtain the binding constant 59±7nM (Figure 4) .
Histochemical Staining of Mouse Brain Tissues
Mice, 24 month old APP +/-/PS1 +/and age-matched control BL/6 (WT), were sacrificed and their brains removed, fixed in 4% formaldehyde, and stored in 30% sucrose for 3 days. Serial brain tissue sections (50 µm) were cut in the coronal plane on a freezing sliding microtome and stored at -20°C 8,9 . Tissue was stained as free-floating sections. Prior to staining, tissue sections were permeabilized with PBS-Tritron-X-100 (0.25%) for 30 minutes, and then blocked with 1% non-fat dry milk in PBS-Ttiton-X-100 for 60 minutes. Tissue sections were incubated with fluorescent molecule 4 (1 µM dissolved in 1% ethanol in PBS) for 60 minutes, and washed 3-times with PBS-Triton-X-100 10 . Thereafter, tissue sections were incubated with mouse-anti-Aβ (mHJ3.4) 8 that was directly conjugated to Alexa 568 for 90 minutes and washed 3-times with PBS-Triton-X-100.
Tissue sections were mounted onto SuperFrost Plus slides, dried overnight at room temperature, and then sealed with Fluoromount G (Southern Biotech, Birmingham, AL). Finally, stained sections were imaged using a Nikon Eclipse E800 epifluorescence microscope.
Histological Staining of Human Brain Tissue
Postmortem brain tissues from autopsy-confirmed AD patients and their approximate agematched healthy controls were obtained through the Knight Alzheimer's Disease Research Center (ADRC) at our institution and processed according to a protocol approved by institutional ADRC executive committees 11 . Formalin-fixed, paraffin embedded tissue sections were obtained from AD brains and age-matched neurological and neuropathological controls. Brain tissue samples were either fixed in 4% formaldehyde, and stored in 30% sucrose for 3 days and sliced (10 µm) a freezing sliding microtome; or tissue was fixed in 10% neutral buffered formal saline, embedded in paraffin wax, and cut at 10 µm. Tissue sections were incubated with either a fluorescent molecule 4 (10 µM) or treated with anti-Aβ (10D5, dilution: 1:10,000; Eli Lilly, Indianapolis, IN) or thioflavin-S. Sections were visualized, processed, and analyzed using a Pascal confocal microscope Multiphoton Imaging 17-month-old APP +/-/PS1 +/mice (harboring dense amyloid plaque accumulation) were imaged using intravital multiphoton microscopy to assess pharmacokinetic profiles of the compound.
Using procedures approved by the Animal Studies Committee at Washington University, thinnedskull cranial windows were prepared on the day prior to imaging, as previously described 12,13 .
Briefly, mice were anesthetized under volatile isoflurane (2% induction, 1.5% maintenance), the scalp and periosteum was removed to expose the skull. A speed drill and microsurgical blade (Surgistar) were used to thin the skull until the skull window (1.5 mM in diameter) was Prior to imaging, mice were intravenously injected with dextran-Texas Red conjugate to mark blood vessels (33mg/kg dissolved in PBS) and 4 (2 mg/kg dissolved in 20% DMSO in 80% propylene glycol) 14 . Three-dimensional volumes were acquired (by collecting a stack of x-y sections starting at the surface of the thinned skull to 100 microns deep into the cortex) for assessing pharmacokinetics of 4 at high resolution in brains of live mice.
______________________________________________________________________________
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